Japanese Pharma Firm Joins Pfizer and Merck in Race to Develop COVID Pill Cure



A Japanese company has started human trials of the first once-a-day pill for COVID-19 patients, joining Pfizer Inc. and Merck & Co. in the race to find treatments for the disease. Well, we know that whoever wins the race will be greatly appreciated, so keep it up!


Read more about it


Photo Credit: James Yarema

9 views0 comments